IOI Corporation Berhad
IOI Corporation Berhad (IOIOF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for IOI Corporation Berhad (IOIOF), covering cash flow, earnings, and balance sheets.
IOI Corporation Berhad (IOIOF) Income Statement & Financial Overview
View the income breakdown for IOI Corporation Berhad IOIOF across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $2.97B | $2.67B | $2.54B | $2.46B |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $2.97B | $2.67B | $2.54B | $2.46B |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $2.20B | $0.00 |
| Operating Expenses | $2.64B | $2.31B | $2.20B | $2.14B |
| Total Costs & Expenses | $2.64B | $2.31B | $2.20B | $2.24B |
| Interest Income | $8.60M | $9.30M | $11.30M | $10.80M |
| Interest Expense | $33.70M | $38.80M | $40.20M | $40.30M |
| Depreciation & Amortization | $100.70M | $101.40M | $92.10M | $103.00M |
| EBITDA | $355.20M | $948.80M | $520.20M | $249.40M |
| EBITDA Ratio | $0.12 | $0.35 | $0.20 | $0.10 |
| Operating Income | $326.50M | $365.00M | $341.70M | $219.80M |
| Operating Income Ratio | $0.11 | $0.14 | $0.13 | $0.09 |
| Other Income/Expenses (Net) | -$214.60M | $443.60M | $86.80M | -$35.50M |
| Income Before Tax | $111.90M | $808.60M | $428.50M | $106.10M |
| Income Before Tax Ratio | $0.04 | $0.30 | $0.17 | $0.04 |
| Income Tax Expense | $105.60M | $89.30M | $80.80M | $60.60M |
| Net Income | $111.10M | $710.70M | $346.90M | $123.10M |
| Net Income Ratio | $0.04 | $0.27 | $0.14 | $0.05 |
| EPS | $0.02 | $0.11 | $0.06 | $0.02 |
| Diluted EPS | $0.02 | $0.11 | $0.06 | $0.02 |
| Weighted Avg Shares Outstanding | $6.20B | $6.20B | $6.20B | $6.20B |
| Weighted Avg Shares Outstanding (Diluted) | $6.20B | $6.20B | $6.20B | $6.20B |
Over the past four quarters, IOI Corporation Berhad demonstrated steady revenue growth, increasing from $2.46B in Q3 2024 to $2.97B in Q2 2025. Operating income reached $326.50M in Q2 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $355.20M, reflecting operational efficiency. Net income dropped to $111.10M, with EPS at $0.02. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan